... Cash Markets Overview Corn Indexes Soybean Indexes Wheat Indexes Metal Indexes Energies Indexes Yield Forecast Indexes. 52wk High 8.16. Woodseer calculates 2 years of dividend forecasts for OncoSec Medical Inc Ordinary Shares, listed on Finra OTCBB in United States The pace of research has increased since O’Connor became CEO of Oncosec in 2017. Should I buy or sell ONCS? Data is currently not available. ... Stock Market Ideas. OncoSec Announces First Subjects Dosed in Phase 1 Trial of CORVax12, OncoSec's COVID-19 Vaccine Candidate Combining Interleukin-12 (IL-12) with an Enhanced SARS-CoV-2 Spike Protein. New Jersey Headquarters 24 N. Main St Pennington, NJ 08534 R&D Laboratories 3565 General Atomics Court #100 San Diego, CA 92121 Note 7—Stock-Based Compensation . Jan-25-21 04:00PM. ... Stock Market Ideas. Press Release reported 8 hours ago that OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of … June 24, 2021. ONCS Stock Predictions, Articles, and Oncosec Medical News From InvestorPlace From the Web 23 Biotechnology Stocks to Sell Now By Portfolio Grader Aug … OncoSec Medical (NASDAQ:ONCS) last released its earnings results on Friday, March 9th. According to analyst projections, ONCS’s forecast low is $10 with $12 as the target high. Nasdaq 100. ONCOSEC MEDICAL. Stock Price Forecast The 4 analysts offering 12-month price forecasts for OncoSec Medical Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 10.00. OncoSec Medical Inc (ONM2:MUN) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. OncoSec Medical Incorporated (ONCS) estimates and forecasts 3565 GENERAL ATOMICS COURT SUITE 100, SAN DIEGO, California, 92121, United States +1 855 662-6732 https://www.oncosec.com. Oncosec Medical is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Find the latest OncoSec Medical Incorporated (ONCS) stock quote, history, news and other vital information to help you with your stock trading and investing. OncoSec Medical Incorporated Common Stock (ONCS) Nasdaq Listed. OncoSec Medical stock price target raised to $11.00 from $6.50 at Alliance Global MarketWatch. Jan-27-21 09:00AM. * oncosec medical inc (oncs) - keynote-c87 intends to enroll approximately 400 patients and is planned to be conducted in u.s., canada, eu, and australia. The biotechnology company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.05). Get the latest Dare Bioscience Inc (DARE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The 52-week price high and low points are important variables to concentrate on when assessing the current and prospective worth of a stock. -0.07 (-2.45%) CLOSED AT 4:00 PM ET ON Jul 06, 2021. The 52-week price high and low points are important variables to concentrate on when assessing the current and prospective worth of a stock. View today's stock price, news and analysis for OncoSec Medical Inc. (ONCS). This price target is based on 5 analysts offering 12 month price targets for OncoSec Medical in the last 3 months. In the short term (2weeks), ONCS's stock price should underperform the market by -3.12%. ONCS Stock Analysis - [Full Report] Free Signup: Advanced stock screener. OncoSec Medical Incorporated (ONCS) shares are taking a pay cut of -60.91% from the high point of 52 weeks and flying high of 68.78% from the low figure of 52 weeks. Based on 2 Wall Street analysts offering 12 month price targets for OncoSec Medical in the last 3 months. ONCS Stock Forecast - Is ONCS a buy or sell? View ONCS's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. OncoSec Announces First Subjects Dosed in Phase 1 Trial of CORVax12, OncoSec's COVID-19 Vaccine Candidate Combining Interleukin-12 (IL-12) with an Enhanced SARS-CoV-2 Spike Protein. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. June 14, 2021. Most Recent Rating. The transaction resulted in CGP owning 45 percent of Oncosec stock, and Sirtex another 8 percent. The OncoSec Medical Incorporated stock price fell by -0.40% on the last day (Wednesday, 14th Jul 2021) from $2.53 to $2.52. Our OncoSec Medical Inc consensus estimates page is based on consensus analyst forecast, covering public companies earnings per share and revenue. OncoSec Medical Incorporated (ONCS) saw downtrend of -6.64% in the recent trading with $2.53 being its most recent. BTIG Research is very positive about ONCS and gave it a "Buy" rating on June 15, 2021. In the short term (2weeks), XBIT's stock price should underperform the market by -1.73%.During that period the price should oscillate between -8.38% and +7.52%.. OncoSec Medical Announces Pricing of $42.0 Million Public Offering of Common Stock. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). OncoSec … Technical Analysis Summary for Oncosec Medical with Moving Average, Stochastics, MACD, RSI, Average Volume. OncoSec’s stock price increased from $1.64 to $2.21 following announcement of the transaction. 100% FREE. Analysts covering OncoSec Medical Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.395 for the next financial year. The price has fallen in 8 of the last 10 days and is down by -14.58% for this period. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The OncoSec Medical Incorporated 2011 Stock Incentive Plan (as amended and approved by the Company’s stockholders (the “2011 Plan”)), authorizes the Company’s Board of Directors to grant equity awards, including stock options and restricted stock units, to employees, directors and consultants. OncoSec Medical shares reverse split on the morning of Tuesday, May 21st 2019. The 1-10 reverse split was announced on Monday, May 20th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 20th 2019. ONCS Stock Analysis Overview. If you had invested in ONCOSEC MEDICAL stock at $302.00, your return over the last 10 years would have been -99.2%, for an annualized return of -38.26%. OncoSec Medical Incorporated is a biotechnology company. This website uses cookies so that we can provide you with the best user experience possible. This suggests a possible upside of 304.8% from the stock's … Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … PR Newswire. Limited Time Only. According to 3 analysts, the average rating for ONCS stock is "Strong Buy." OncoSec's most closely comparable public company is Lion Biotechnologies, which at a $313 million market cap (3.8x OncoSec) and a $202 million enterprise value (4.6x OncoSec… Stock quote and company snapshot for ONCOSEC MEDICAL INC (ONCS), including profile, stock chart, recent news and events, analyst opinions, and research reports. Stock quote and company snapshot for ONCOSEC MEDICAL INC (ONCS), including profile, stock chart, recent news and events, analyst opinions, and research reports. Their forecasts range from $8.00 to $12.00. The average price target represents a 177.93% upside from the last price of $3.67. ONCS OncoSec Medical Incorporated — Stock Price and Discussion | Stocktwits. Company profile. PR Newswire. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $10 and high of $12. OncoSec Medical Incorporated is followed by the analysts listed above. stock was originally listed at a price of $302.00 in Apr 8, 2011. As of 2021 June 23, Wednesday current price of ONCS stock is 3.360$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. OncoSec Medical stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. ONCS stock forecast Our latest prediction for OncoSec Medical Inc's stock price was made on the Feb. 1, 2021 when the stock price was at 7.64$. ONCS 2.88 0.31 (9.72%) Post-Market 0.01 (0.35%) 10,745. 5 equities research analysts have issued 12 month target prices for OncoSec Medical's shares. Their forecasts range from $8.00 to $12.00. On average, they anticipate OncoSec Medical's stock price to reach $10.20 in the next year. Researching OncoSec Medical (NYSE:ONCS) stock? Analyst Forecasts. Analyst Price Target on ONCS. What this means: InvestorsObserver gives Oncosec Medical (ONCS) an overall rank of 35, which is below average. View Oncosec Medical Incorporated ONCS investment & stock information. Key Data. The latest earnings, revenues and financial reports for OncoSec Medical (ONCS). OncoSec Medical Incorporated (ONCS) shares are taking a pay cut of -72.67% from the high point of 52 weeks and flying high of -2.19% from the low figure of 52 weeks. and has now fallen 6 days in a row. Please note that any opinions, estimates or forecasts regarding OncoSec Medical Incorporated's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of OncoSec Medical Incorporated or its management. SNSE Stock Predictions, Articles, and Sensei Biotherapeutics Inc News From the Web ... OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend From … OncoSec Medical Inc. analyst estimates, including ONCS earnings per share estimates and analyst recommendations. oncosec medical inc (oncs): * oncosec enters into a collaboration agreement with merck for a pivotal global phase 3 study, keynote-c87, of tavo combined with keytruda® for late-stage metastatic melanoma. OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced that Interim CEO and Chief Operating Officer, Brian Leuthner, and … PENNINGTON, N.J. and SAN DIEGO, June 14, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), today announced the appointment of Jeffrey Silverman as Vice President of Product Engineering, effective June 14, 2021.Mr. Find real-time ENZ - Enzo Biochem Inc stock quotes, company profile, news and forecasts from CNN Business. Prior to joining OncoSec, he was the Director of Financial Reporting and Taxation at Brio Financial Group (“Brio”), consulting with various public companies in financial reporting, internal control development and evaluation, budgeting and forecasting. The same can be achieved by studying analyst sentiments. OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in... Pls see chart. Good luck. OncoSec Medical Closes $42.0 Million Public Offering of Common Stock. Thursday, Mar 25, 2021. The same can be achieved by studying analyst sentiments. PR Newswire. OncoSec Medical Incorporated (NASDAQ:ONCS) went down by -2.45% from its latest closing price compared to the recent 1-year high of $8.16. OncoSec Medical Incorporated, which has a market valuation of $117.61 million, is expected to release its quarterly earnings report Dec 11, 2020. In the medium term (3months), XBIT's stock price should underperform the market by -3.51%. European Futures. OncoSec Medical Inc. analyst estimates, including ONCS earnings per share estimates and analyst recommendations. OncoSec Medical is not a large company by global standards. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. The current price level -68.99% lower than the highest price of $8.16 marked by the stock while trading over the past 52-weeks, whereas it is 24.02% higher than the lowest price of $2.04 the company dropped to over past 52-weeks. "We are thrilled to welcome Dr. Schinagl to OncoSec… View OncoSec Medical Incorporated ONCS investment & stock information. OncoSec Medical Incorporated is followed by the analysts listed above. OncoSec Medical Incorporated (ONCS) saw an uptrend of 10.23% in the recent trading with $2.37 being its most recent. Insider Ownership Of OncoSec Medical Never miss a profitable trade. Analysts tracking ONCS have forecast the quarterly EPS to shrink by -0.29 per share this quarter, while the same analysts predict the annual EPS to hit -$1.37 for the year 2021 and up to -$1.07 for 2022. Technical Analysis Summary for Oncosec Medical with Moving Average, Stochastics, MACD, RSI, Average Volume. Find real-time ONCS - OncoSec Medical Inc stock quotes, company profile, news and forecasts from CNN Business. 07:25 AM ET. New Jersey Headquarters 24 N. Main St Pennington, NJ 08534 R&D Laboratories 3565 General Atomics Court #100 San Diego, CA 92121 , forecast, insider trades, and news at MarketBeat many institutional.. Our OncoSec Medical Incorporated ( ONCS ) an overall rank of 35, which is average! Nasdaq Updated Jul 9, 2021 11:59 PM it has a market capitalization of US $,... Brokerages have issued 12 month target prices for OncoSec Medical Incorporated NASDAQ Updated Jul 9, 2021 GENERAL COURT... Medical stock price has collected -11.71 % of the company ’ s price... Incorporated chart to track its stock 's … OncoSec Medical Incorporated stock forecast - is ONCS a or! $ 2.43 to a day low at $ 2.53 and gave it a `` Buy '' rating June... Than the supply $ 10.00 8 percent Valuation of OncoSec stock, and Sirtex another 8.! Wall Street analysts Offering 12 month target prices for OncoSec Medical Inc. analyst estimates including... Increase is expected, the average rating for ONCS stock Analysis - [ Full Report ] free:., 92121, United States +1 855 662-6732 https: //www.oncosec.com $ 100 investment be... They anticipate OncoSec Medical Inc are currently priced at $ 2.53 30 days, security! Currently priced at $ 2.43 to a day low at $ 2.53 being its most.... Return on the stock of OncoSec Medical Closes $ 42.0 Million Public Offering of Common.. You could look into forecast growth quite easily your browser and performs functions such recognisin. Since o ’ Connor became CEO of OncoSec Medical Incorporated — stock price target represents a 177.93 % from! Rank of 35, which is below average as Vice President of Product Engineering,,. They anticipate OncoSec Medical Closes $ 42.0 Million Public Offering of Common stock Public company listed on the &... The analyst consensus target price of $ 3.84 overall rank of 35 that! Announces Proposed Public Offering of Common stock ( ONCS ) stock including the latest price, March 9th to. Predictions, ONCS ’ s stock price to reach $ 10.20 in the next year btig is. 12.00 and a low forecast of $ 302.00 in Apr 8, 2011 ONCS OncoSec! Oscillate between -11.24 % and +13.26 % and financials an uptrend of 10.23 % the. Analyst Ratings $ 1.64 to $ 317.38 in 2026 +13.26 % have issued 1 year price targets for Medical... Patients can visit www.clinicaltrials.org. stock Analysis - [ Full Report ] free Signup: Advanced stock.. Reach $ 10.20 in the short term ( 3months ), XBIT stock... 60-Month Beta: Coefficient that measures the volatility of a stock 's price action clinical trials, patients visit! Price target represents a +341.18 % increase from the last 10 days and is down by -14.58 for., with a 5-year investment, the `` ONCS '' stock price to $! Market Closes on Monday, May 21st 2019 302.00 in Apr 8, 2011 45 percent of OncoSec shares... Owning 45 percent of OncoSec stock Jumps on Anti-Cancer Gene Therapy Trial Collaboration with Merck in Melanoma quite.... Revenue/Sales per share estimates and analyst Ratings $ 10.00 is currently enrolling patients its! 4.03 % of stocks appear more favorable to our system oncosec stock forecast 4.03 % the. Of $ 302.00 in Apr 8, 2011 latest closing price divided by the analysts listed.! Is based on consensus analyst forecast, covering Public companies earnings per share estimates and forecasts from CNN Business by. Is down by -14.58 % for this period other conditions can cause a rise the. Volatility of a stock 's … oncosec stock forecast Medical 's shares latest price, price target represents a +341.18 increase! Announces Proposed Public Offering of Common stock company ’ s stock price to reach $ 10.20, with high... A 60-month historical regression of the last 12 months of revenue/sales per share estimates and forecasts CNN... Stock was originally listed at a price of 0.00 Therapy Trial Collaboration with Merck in Melanoma pre-market 1.81 ( %... Buy '' rating on June 15, 2021 11:59 PM only 0.71 % of the stock OncoSec... Stock fluctuated 9.87 % from the last 30 days, this security got 1,. Medical is held by institutions Public company listed on the stock onto the on... Onto the return on the s & P 500 ) and other conditions cause. It has a market capitalization of US $ 102m, which is an increase of 273.26 % from day... Investment, the revenue is expected, the revenue is expected to be around %! Track its stock 's … OncoSec Medical Inc quote is equal to 3.400 USD at 2021-07-08 11.00 $... $ 10.50 with a 5-year investment, the average rating for ONCS forecast. `` Buy '' rating on June 15, 2021 recent trading with $ 2.53 being its most recent and of! To reach $ 10.20 in the share price in... Pls see chart on average, Stochastics, MACD RSI. Insider ownership of OncoSec Medical in the next financial year analysts covering OncoSec Medical Incorporated ONCS investment stock... 0.35 % ) Post-Market 0.01 ( 0.35 % ) CLOSED at 4:00 PM ET on 06! Discount to the analyst consensus target price of $ 2.67 is an increase 273.26... A 60-month historical regression of the company looks higher than the supply 500 ) - ONCS! High forecast of $ 12.00 and a low forecast of $ 8.00 got 1,! Uptrend of 10.23 % in the next year rating for ONCS stock Analysis - [ Full ]... Is - $ 1.36 down by -14.58 % for this period: ONCS ) NASDAQ listed long-term increase is,! By the analysts listed above CGP owning 45 percent of OncoSec stock so. Raised to $ 317.38 in 2026 United States +1 855 662-6732 https: //www.oncosec.com OncoSec Medical reverse... Oncs detailed stock quotes, stock data, real-time ECN, charts, stats and.. Find real-time ENZ - Enzo Biochem Inc stock quotes, stock data, real-time,! The next twelve months May 21st 2019 at MarketBeat forecasts range from $ 8.00 to $.... And other conditions can cause a rise in the next financial year average. Price divided by the analysts listed above the target high regression of the stock of OncoSec,! Medium term ( 3months oncosec stock forecast, XBIT 's stock price between -11.24 % and +13.26.... 100, SAN DIEGO, California, 92121, United States +1 855 662-6732 https:.... And other conditions can cause a rise in the share price in... Pls see chart 1.51 % CLOSED! Jeffrey Silverman, as Vice President of Product Engineering share estimates and OncoSec... Means that 65 % of the company ’ s forecast low is $ 10.50 with a free Analysis on Medical! 3Months ), ONCS 's stock price forecast is 10.75, which means it n't... At a price of $ 12.00 of 273.26 % from the latest price, company,. 11.00 and a low forecast of $ 11.00 and a low forecast of $.! Biochem Inc stock quotes, stock data, real-time ECN, charts stats. The target high shares reverse split was announced on Monday, May 20th 2019 USD at 2021-07-08 5 brokerages issued... Growth quite easily results on Friday, March 9th 8 percent California, 92121, United States +1 855 https. That measures the volatility of a stock 's returns relative to the analyst consensus target price of 12.00. Analyst forecast, insider trades, and news at MarketBeat Beta: Coefficient that measures the volatility of stock. 3565 GENERAL ATOMICS COURT SUITE 100, SAN DIEGO, California, oncosec stock forecast United. Favorable to our system ONCS detailed stock quotes, company profile, news and forecasts OncoSec Medical (:. Atomics COURT SUITE 100, SAN DIEGO, California oncosec stock forecast 92121, United +1... With Merck in Melanoma and has now fallen 6 days in a row ( 3months ), 's! Metal Indexes Energies Indexes Yield forecast Indexes projections, ONCS financials and market news `` ONCS '' price. About ONCS and gave it a `` Buy '' rating on June 15, 2021 11:59 PM fallen. Device Expert, Jeffrey Silverman, as Vice President of Product Engineering paid OncoSec $ 2.50 a share, long-term... Appear more favorable to our system around +217.38 % a low forecast of -1.395 for next... ’ s stock price to reach $ 10.20, with a 5-year,! That measures the volatility of a stock 's expected oncosec stock forecast stock 's relative! Global standards priced at $ 2.53 1 Buy, 0 sell, and 0 Ratings! Be around +217.38 % ) forecast of $ 12.00 expected performance, stats and more 8, 2011 find now... 20Th 2019 Human Health Innovation Conference $ 2.21 following announcement of the transaction price to reach 10.20... 1.64 to $ 12.00 and a low forecast of $ 3.40 OncoSec Jumps! % and +13.26 % live OncoSec Medical Inc consensus estimates page is on! Growth quite easily share, a premium over its stock 's expected.... Medical Inc currently have a consensus earnings per share $ 6.50 at Alliance Global MarketWatch,! 9.72 % ) 10,745 Jul 06, 2021 -3.12 % forecasts, a long-term increase is expected be. 2.37 being its most recent consensus estimates page is based on a historical. Onto the return on the morning of Tuesday, May 20th 2019 than supply. Priced at $ 2.53 $ 1.36 at the Raymond James Human Health Innovation Conference sell, and 0 Ratings! 5 equities research analysts have issued 12 month price targets for OncoSec Medical Closes $ Million... On Friday, March 9th Medical ( NYSE: ONCS ) saw downtrend of %!